Cardlytics Inc (CDLX) — Cash Flow Reinvestment Rate
Latest as of December 2025:
0.00x
Cardlytics Inc (CDLX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting $25.00K (capex $25.00K ) from operating cash flow of $13.01 Million. See Cardlytics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$25.00K
Capex + Investments
Operating Cash Flow
$13.01 Million
USD
Capital Expenditures
$25.00K
USD
Cardlytics Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Cardlytics Inc across 2 annual periods. For the full cash flow conversion analysis, see Cardlytics Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for Cardlytics Inc (2019–2025)
Year-by-year capital reinvestment analysis for Cardlytics Inc. See financial agility of Cardlytics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.05x | $480.00K | $9.29 Million | $480.00K | ▼ -97.3% |
| 2019 | 1.92x | $22.04 Million | $11.46 Million | $11.02 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow